<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <article xmlns="" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
      <head>
         <style type="text/css"> 		 
            	    table {background : #ffffdd;}
            		 	tr {background : #ddddff; padding : 1px;}
            			
         </style>
         <span class="citation_publisher">Hindawi Publishing Corporation</span>
         <h2 class="citation-title">Electrocardiography as the First Step for the Further Examination of Cardiac Involvement
            in Myasthenia Gravis
         </h2>
         <span class="doi">10.1155/2016/8058946</span>
         <div class="contrib-group">contrib: 
            	  CONT
            	  
            <span class="citation_author">Takao Kato</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Sayako Hirose</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Shogo Kumagai</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Akihiko Ozaki</span>
            <span class="citation_author_institution_ref">3</span>
            <span class="citation_author">Sadayuki Matsumoto</span>
            <span class="citation_author_institution_ref">3</span>
            <span class="citation_author">Moriaki Inoko</span>
            <span class="citation_author_institution_ref">1</span>
         </div>
         <span class="email">[takao-kato@kitano-hp.or.jp]</span>
         <span class="conflict">[]</span>
         <span class="contribs">[]</span>
         <span class="citation_pubdate">[2016-1-17]</span>
         <span class="citation_copyright">[Copyright 2016: ]</span>
         <span class="citation_licence">[Licence This is an open access article distributed under the Creative Commons Attribution
            License, which permits unrestricted use, distribution, and reproduction in any medium,
            provided the original work is properly cited.]
         </span>
         <span class="citation_funding">[]</span>
         <span class="citation_pagecount">[]</span>
         <span class="citation_data">[]</span>
      </head>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p>
            <i>Introduction</i>. Cardiac involvement of myasthenia gravis (MG) accompanies a poor prognosis. In the
            present study, we aimed to investigate the relationship between ECG abnormality and
            cardiac involvement.
            <i> Methods</i>. Of 178 patients diagnosed with MG between 2001 and 2013 at our hospital, we retrospectively
            analyzed consecutive 58 patients who underwent both ECG and echocardiography and without
            underlying cardiovascular disease. ECG abnormalities were defined by computer-assigned
            Minnesota-codes. Cardiac damage was defined as either (1) ejection fraction (EF) &lt;55%
            on echocardiography or (2) elevated 
            <i>E</i>/
            <i>e</i>′, the ratio of mitral velocity to early diastolic velocity of the mitral annulus
            &gt;8 on echocardiography.
            <i> Results</i>. Thirty-three patients (56.8%) had ECG abnormality. An elevated 
            <i>E</i>/
            <i>e</i>′ was observed in patients with ECG abnormality compared to those without ECG abnormality
            (11.2 ± 3.2, 8.7 ± 2.2, resp., 
            <i>p</i> = 0.03). Among patients with ECG abnormality, 14 of 15 patients showed cardiac damage.
            Among patients without ECG abnormality, 6 of 33 patients showed cardiac damage (
            <i>p</i> = 0.003). Reduced EF was observed in five patients (8.6%) with ECG abnormality and
            none in patients without ECG abnormality.
            <i> Conclusions</i>. ECG may aid as the first step for the further examination of cardiac damage in patients
            with MG.
         </p>
      </div>
      <div tagxxx="sec">
         <title>1. Introduction</title>
         <p>Myasthenia gravis (MG) primarily affects skeletal muscle via production of autoantibodies
            against nicotinic acetylcholine receptors in the motor endplates; heart muscle is
            a rare autoimmune target [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>]. Patients with MG may show several kinds of cardiac involvement, ranging from asymptomatic
            changes on electrocardiography (ECG) to ventricular tachycardia, myocarditis, conduction
            disorder, heart failure, and sudden death [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B5">
               <sup>
                  <a href="#B5">5</a>
               </sup>
            </span>]. Detection of cardiac involvement in MG is important because this cardiomyopathy
            may be treatable [
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">4</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B5">
               <sup>
                  <a href="#B5">5</a>
               </sup>
            </span>]. In the present study, we aimed to investigate the relationship between ECG abnormality
            and cardiac damage by echocardiography in order to aid in early detection and timely
            treatment.
         </p>
      </div>
      <div tagxxx="sec">
         <title>2. Methods</title>
         <p>Of 178 patients diagnosed with MG between 2001 and 2013 at our hospital, we retrospectively
            analyzed consecutive 58 patients who underwent both ECG and echocardiographic examinations
            and without underlying cardiovascular disease (ischemic heart disease, valvular heart
            disease, and hypertensive heart disease). ECG abnormalities were defined by standardized
            computer-assigned Minnesota-codes [
            <span ref-type="bibr" rid="B6">
               <sup>
                  <a href="#B6">6</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">7</a>
               </sup>
            </span>]. Echocardiography was performed by cardiac sonographers according to the guidelines
            [
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">8</a>
               </sup>
            </span>].
         </p>
         <p>Cardiac damage was defined as either (1) ejection fraction (EF) &lt;55% on echocardiography
            (the EF of a normal heart may be between 55% and 70%) according to the practice guideline
            [
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">8</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B9">
               <sup>
                  <a href="#B9">9</a>
               </sup>
            </span>] or (2) elevated 
            <i>E</i>/
            <i>e</i>′, the ratio of mitral velocity to early diastolic velocity of the mitral annulus
            (
            <i>E</i>/
            <i>e</i>′) &gt;8 on echocardiography (the 
            <i>E</i>/
            <i>e</i>′ of a normal left ventricular end-diastolic pressure may be &lt;8) [
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">8</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">10</a>
               </sup>
            </span>].
         </p>
         <p>The study conformed to the ethical guidelines of the 1975 Declaration of Helsinki
            and was approved by the Institutional Review Board of Kitano Hospital. All data are
            expressed as mean ± SD. Differences between groups were compared by using the Mann-Whitney
            
            <i>U</i> test, while categorical variables were compared by using Pearson's chi-square test.
            In all tests, 
            <i>p</i> values of &lt;0.05 were considered significant.
         </p>
      </div>
      <div tagxxx="sec">
         <title>3. Results</title>
         <p>Thirty-three patients (56.8%) had ECG abnormality: 10.3% had atrial fibrillation,
            6.8% had atrioventricular block, 29.3% had nonspecific ST depression, and 29.3% had
            negative T wave (
            <span ref-type="table" rid="tab1">
               <a href="#tab1">Table 1</a>
            </span>). There were no differences in comorbidities or clinical characteristics of MG patients
            with or without ECG abnormality (
            <span ref-type="table" rid="tab2">
               <a href="#tab2">Table 2</a>
            </span>). On echocardiography, there was a difference in 
            <i>E</i>/
            <i>e</i>′ between patients with or without ECG abnormality (11.2 ± 3.2, 8.7 ± 2.2, resp.,
            
            <i>p</i> = 0.03, 
            <span ref-type="table" rid="tab3">
               <a href="#tab3">Table 3</a>
            </span>). Among patients with ECG abnormality, 14 of 15 patients showed the suggested cardiac
            damage. Among patients without ECG abnormality, 6 of 33 patients showed the suggested
            cardiac damage (
            <i>p</i> = 0.003, 
            <span ref-type="table" rid="tab4">
               <a href="#tab4">Table 4</a>
            </span>). The sensitivity of ECG abnormality for detecting cardiac damage was 0.700 (95%
            confidence interval [CI], 0.525–0.836), while its specificity was 0.711 (95% CI, 0.618–0.782).
            The positive predictive value was 0.560 (95% CI, 0.420–0.669), while the negative
            predictive value was 0.818 (95% CI, 0.712–0.901).
         </p>
         <p>When we limited the cases by reduced EF, five patients (8.6%) had reduced EF (EFs
            of 10%, 26%, 43%, 49%, and 54%, resp.) with diffuse hypokinesis; all 5 had ECG abnormality
            with high 
            <i>E</i>/
            <i>e</i>′ values of 12 ± 3.6. Among patients without ECG abnormality, none of the patients
            showed reduced EF. Of the 5 patients with reduced EF, 1 patient with an EF of 30%
            died of colon cancer, and 4 patients were administered immunosuppressive therapy.
            Three of the 4 patients with EFs of 43%, 47%, and 54%, respectively, had a good clinical
            course, while 1 patient with an EF of 10% died of acute decompensated heart failure
            approximately 1 month after self-discontinuation of immunosuppressive therapy.
         </p>
      </div>
      <div tagxxx="sec">
         <title>4. Discussion</title>
         <p>Cardiac manifestation is thought to be relatively rare in MG. However, it has been
            reported that approximately 16% of patients with MG have various cardiac manifestations,
            such as arrhythmia and heart failure [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>]. Autoimmunologic mechanisms are considered to be contributory to such cardiac involvement
            [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>], such as the antibody for ryanodine receptor (RyR), the antibody for both beta 1
            and beta 2 adrenergic receptors, the anti-titin antibodies, and the antibody for Kv1.4—a
            muscular voltage-gated potassium channel [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>]. Arrhythmia is the most common clinical manifestation of unexplained cardiac disease
            in MG, occurring in as many as 8% of cases [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>], which is consistent with the findings of the present study. The prevalence of abnormal
            ECG is also reported varying from 16% to 88% of patients with MG [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B11">
               <sup>
                  <a href="#B11">11</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B12">
               <sup>
                  <a href="#B12">12</a>
               </sup>
            </span>], probably due to the inclusivity of MG patients who underwent ECG; however, no demonstration
            of any clinical significance was provided. This study validated the presence of ECG
            abnormality in patients with MG, including arrhythmia, conduction abnormality, and
            the abnormality of ST portion and T wave. We also showed that a small number of patients
            without ECG abnormality demonstrated cardiac damage, which comprised only diastolic
            impairment and did not include systolic impairment. These results implied the utility
            of ECG. If the abnormality exists, further examination by echocardiography may be
            necessary for the detection of systolic impairment in patients with MG, which indicates
            a poor prognosis but can be treated by immunosuppressant therapy [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">4</a>
               </sup>
            </span>]. Therefore, the presence or absence of ECG abnormality may be useful as the first
            step for the further examination of cardiac damage in patients with MG.
         </p>
         <p>Cardiac investigation in patients with MG with unexplained fatigue should comprise
            a physical examination including third tone, holosystolic murmurs, ankle swelling,
            or lung rales; laboratory findings including brain natriuretic peptide (BNP) [
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">8</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">10</a>
               </sup>
            </span>] and cardiac troponin [
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">4</a>
               </sup>
            </span>]; 6-minute walk distance [
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">13</a>
               </sup>
            </span>]; and echocardiography along with ECG. Diastolic impairment also affects the exercise
            intolerance and it is more likely to cause atrial fibrillation. 
            <i>E</i>/
            <i>e</i>′ in particular closely correlates with left ventricular filling pressure. Several
            prominent validation studies have confirmed this correlation and noted that the prediction
            of normal or abnormal filling pressure is most reliable when the ratio is &lt;8 or &gt;15,
            respectively [
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">14</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B15">
               <sup>
                  <a href="#B15">15</a>
               </sup>
            </span>]. In our study, the 
            <i>E</i>/
            <i>e</i>′ values were relatively high (mean: 10.46 ± 3.24) in patients in MG. There is a possibility
            that diastolic function was reduced in patients with MG. The diameter of the left
            atrium tends to be larger in patients with ECG abnormality; however, the combined
            measurement of BNP or N-terminal pro-BNP levels requires validation [
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">8</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">10</a>
               </sup>
            </span>]. The mechanism underlying the high 
            <i>E</i>/
            <i>e</i>′ could be explained, at least partly, by the disturbance of calcium handling related
            to ryanodine receptors [
            <span ref-type="bibr" rid="B16">
               <sup>
                  <a href="#B16">16</a>
               </sup>
            </span>], which are one of the targets of autoimmunity in patients with MG [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>]. A large-scale, long-term study is needed for verification, while the mechanism
            and clinical significance of diastolic dysfunction also remain to be elucidated.
         </p>
         <p>There are several limitations of the present study. First, not all the patients with
            MG underwent ECG and echocardiographic examinations at our hospital and a selection
            bias may exist. Therefore, further prospective large-scale study or the analysis of
            consecutive cases is warranted to validate ECG as a useful tool for the screening
            method of cardiac dysfunction in all patients with MG. Second, coronary artery disease
            could not be excluded entirely in these patients with MG, even though regional abnormality
            of wall motion, consistent with coronary artery disease, was not found in the present
            study. Third, whether an exercise test provoked the reduction of EF was not verified
            in the present study. BNP (or N-terminal pro-BNP) levels and physical findings were
            inadequate to be acquired. However, due to the rarity of the MG with cardiac involvement,
            this retrospective study has a clinical insight for the detection of systolic or diastolic
            dysfunction in patients with MG.
         </p>
      </div>
      <div tagxxx="sec">
         <title>5. Conclusions</title>
         <p>ECG may aid as the first step for the further examination of cardiac damage in patients
            with MG.
         </p>
      </div>
      <back>
         <div tagxxx="ack">
            <title>Acknowledgment</title>
            <p>This study was supported by the Tazuke Kofukai Medical Research Institute.</p>
         </div>
         <div tagxxx="sec">
            <title>Conflict of Interests</title>
            <p>The authors report no relationships that could be construed as a conflict of interests.</p>
         </div>
         <div tagxxx="sec">
            <title>Authors' Contribution</title>
            <p>Takao Kato and Sayako Hirose conceived and designed the experiments. Takao Kato, Sayako
               Hirose, and Shogo Kumagai analyzed the data. Takao Kato wrote the paper. Akihiko Ozaki,
               Sadayuki Matsumoto, and Moriaki Inoko critically reviewed the paper.
            </p>
         </div>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <a name="B1"></a>
                  <label>1</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Hofstad</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ohm</span>
                           <span tagx="given-names">O.-J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mork</span>
                           <span tagx="given-names">S. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Aarli</span>
                           <span tagx="given-names">J. A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Heart disease in myasthenia gravis</span>
                     <span tagx="source">
                        <i>Acta Neurologica Scandinavica</i>
                     </span>
                     <span tagx="year">1984</span>
                     <span tagx="volume">70</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">176</span>
                     <span tagx="lpage">184</span>
                     <span class="pub-id'">[2-s2.0-0021144392]</span>
                     <span class="pub-id'">[6507031]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <label>2</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Suzuki</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Utsugisawa</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Yoshikawa</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Autoimmune targets of heart and skeletal muscles in myasthenia gravis</span>
                     <span tagx="source">
                        <i>Archives of Neurology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">66</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">1334</span>
                     <span tagx="lpage">1338</span>
                     <span class="pub-id'">[10.1001/archneurol.2009.229]</span>
                     <span class="pub-id'">[2-s2.0-70449650324]</span>
                     <span class="pub-id'">[19752287]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <label>3</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">de Jongste</span>
                           <span tagx="given-names">M. J. L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Oosterhuis</span>
                           <span tagx="given-names">H. J. G. H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lie</span>
                           <span tagx="given-names">K. I.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Intractable ventricular tachycardia in a patient with giant cell myocarditis, thymoma
                        and myasthenia gravis
                     </span>
                     <span tagx="source">
                        <i>International Journal of Cardiology</i>
                     </span>
                     <span tagx="year">1986</span>
                     <span tagx="volume">13</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">374</span>
                     <span tagx="lpage">378</span>
                     <span class="pub-id'">[10.1016/0167-5273(86)90124-5]</span>
                     <span class="pub-id'">[2-s2.0-0023025646]</span>
                     <span class="pub-id'">[3793292]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <label>4</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Kumagai</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kato</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ozaki</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Letter to the editor: serial measurements of cardiac troponin i in patients with myasthenia
                        gravis-related cardiomyopathy
                     </span>
                     <span tagx="source">
                        <i>International Journal of Cardiology</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">168</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">e79</span>
                     <span tagx="lpage">e80</span>
                     <span class="pub-id'">[10.1016/j.ijcard.2013.07.046]</span>
                     <span class="pub-id'">[2-s2.0-84885320234]</span>
                     <span class="pub-id'">[23886525]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <label>5</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Venturini</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pellegrinetti</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Marabotti</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Magni</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Testa</span>
                           <span tagx="given-names">R.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Myasthenia gravis and heart failure: is ivabradine a useful drug?</span>
                     <span tagx="source">
                        <i>International Journal of Cardiology</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">174</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">e4</span>
                     <span tagx="lpage">e6</span>
                     <span class="pub-id'">[10.1016/j.ijcard.2014.03.202]</span>
                     <span class="pub-id'">[2-s2.0-84901244161]</span>
                     <span class="pub-id'">[24746503]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B6"></a>
                  <label>6</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Prineas</span>
                           <span tagx="given-names">R. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Crow</span>
                           <span tagx="given-names">R. S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Blackburn</span>
                           <span tagx="given-names">H.</span>
                        </name>
                     </span>
                     <span tagx="source">
                        <i>The Minnesota Code Manual of Electrocardiographic. Findings: Standards and Procedures
                           for Measurement and Classification
                        </i>
                     </span>
                     <span tagx="year">1982</span>
                     <span class="publisher-loc'">[Boston, Mass, USA]</span>
                     <span class="publisher-name'">[John Wright, PSG]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <label>7</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Kors</span>
                           <span tagx="given-names">J. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Crow</span>
                           <span tagx="given-names">R. S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hannan</span>
                           <span tagx="given-names">P. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rautaharju</span>
                           <span tagx="given-names">P. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Folsom</span>
                           <span tagx="given-names">A. R.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Comparison of computer-assigned Minnesota codes with the visual standard method for
                        new coronary heart disease events
                     </span>
                     <span tagx="source">
                        <i>American Journal of Epidemiology</i>
                     </span>
                     <span tagx="year">2000</span>
                     <span tagx="volume">151</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">790</span>
                     <span tagx="lpage">797</span>
                     <span class="pub-id'">[10.1093/oxfordjournals.aje.a010279]</span>
                     <span class="pub-id'">[2-s2.0-0034655016]</span>
                     <span class="pub-id'">[10965976]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <label>8</label>
                  <span class="element-citation'">
                     <span class="collab'">[Japanese Circulation Society]</span>
                     <span tagx="article-title">Guidelines for the clinical application of echocardiography</span>
                     <span tagx="source">
                        <i>Circulation Journal</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">69</span>
                     <span tagx="fpage">1409</span>
                     <span tagx="lpage">1445</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <label>9</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Yancy</span>
                           <span tagx="given-names">C. W.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jessup</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Bozkurt</span>
                           <span tagx="given-names">B.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">2013 ACCF/AHA guideline for the management of heart failure: a report of the American
                        College of Cardiology Foundation/American Heart Association Task Force on Practice
                        Guidelines
                     </span>
                     <span tagx="source">
                        <i>Journal of the American College of Cardiology</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">62</span>
                     <div tagxxx="issue">16</div>
                     <span tagx="fpage">e147</span>
                     <span tagx="lpage">e239</span>
                     <span class="pub-id'">[10.1016/j.jacc.2013.05.019]</span>
                     <span class="pub-id'">[2-s2.0-84884294190]</span>
                     <span class="pub-id'">[23747642]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <label>10</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Nagueh</span>
                           <span tagx="given-names">S. F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Appleton</span>
                           <span tagx="given-names">C. P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gillebert</span>
                           <span tagx="given-names">T. C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Recommendations for the evaluation of left ventricular diastolic function by echocardiography</span>
                     <span tagx="source">
                        <i>Journal of the American Society of Echocardiography</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">22</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">107</span>
                     <span tagx="lpage">133</span>
                     <span class="pub-id'">[10.1016/j.echo.2008.11.023]</span>
                     <span class="pub-id'">[2-s2.0-58849121949]</span>
                     <span class="pub-id'">[19187853]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <label>11</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Xu</span>
                           <span tagx="given-names">B.-Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pirskanen</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kari Lefvert</span>
                           <span tagx="given-names">A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Antibodies against 
                        <i>β</i>1 and 
                        <i>β</i>2 adrenergic receptors in myasthenia gravis
                     </span>
                     <span tagx="source">
                        <i>Journal of Neuroimmunology</i>
                     </span>
                     <span tagx="year">1998</span>
                     <span tagx="volume">91</span>
                     <div tagxxx="issue">1-2</div>
                     <span tagx="fpage">82</span>
                     <span tagx="lpage">88</span>
                     <span class="pub-id'">[10.1016/S0165-5728(98)00159-3]</span>
                     <span class="pub-id'">[2-s2.0-0032476753]</span>
                     <span class="pub-id'">[9846822]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <label>12</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gibson</span>
                           <span tagx="given-names">T. C.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The heart in myasthenia gravis</span>
                     <span tagx="source">
                        <i>American Heart Journal</i>
                     </span>
                     <span tagx="year">1975</span>
                     <span tagx="volume">90</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">389</span>
                     <span tagx="lpage">396</span>
                     <span class="pub-id'">[10.1016/0002-8703(75)90330-0]</span>
                     <span class="pub-id'">[2-s2.0-0016828958]</span>
                     <span class="pub-id'">[1099888]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <label>13</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ingle</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Cleland</span>
                           <span tagx="given-names">J. G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Clark</span>
                           <span tagx="given-names">A. L.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The long-term prognostic significance of 6-minute walk test distance in patients with
                        chronic heart failure
                     </span>
                     <span tagx="source">
                        <i>BioMed Research International</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">2014</span>
                     <span tagx="fpage">7</span>
                     <span class="pub-id'">[505969]</span>
                     <span class="pub-id'">[10.1155/2014/505969]</span>
                     <span class="pub-id'">[2-s2.0-84899519416]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <label>14</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ommen</span>
                           <span tagx="given-names">S. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Nishimura</span>
                           <span tagx="given-names">R. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Appleton</span>
                           <span tagx="given-names">C. P.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation
                        of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization
                        study
                     </span>
                     <span tagx="source">
                        <i>Circulation</i>
                     </span>
                     <span tagx="year">2000</span>
                     <span tagx="volume">102</span>
                     <div tagxxx="issue">15</div>
                     <span tagx="fpage">1788</span>
                     <span tagx="lpage">1794</span>
                     <span class="pub-id'">[10.1161/01.cir.102.15.1788]</span>
                     <span class="pub-id'">[2-s2.0-0034633812]</span>
                     <span class="pub-id'">[11023933]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <label>15</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Nagueh</span>
                           <span tagx="given-names">S. F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mikati</span>
                           <span tagx="given-names">I.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kopelen</span>
                           <span tagx="given-names">H. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Middleton</span>
                           <span tagx="given-names">K. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Quiñones</span>
                           <span tagx="given-names">M. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Zoghbi</span>
                           <span tagx="given-names">W. A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new
                        application of tissue Doppler imaging
                     </span>
                     <span tagx="source">
                        <i>Circulation</i>
                     </span>
                     <span tagx="year">1998</span>
                     <span tagx="volume">98</span>
                     <div tagxxx="issue">16</div>
                     <span tagx="fpage">1644</span>
                     <span tagx="lpage">1650</span>
                     <span class="pub-id'">[10.1161/01.CIR.98.16.1644]</span>
                     <span class="pub-id'">[2-s2.0-0032552904]</span>
                     <span class="pub-id'">[9778330]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B16"></a>
                  <label>16</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Lacombe</span>
                           <span tagx="given-names">V. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Viatchenko-Karpinski</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Terentyev</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction
                        in diabetes
                     </span>
                     <span tagx="source">
                        <i>The American Journal of Physiology—Regulatory Integrative and Comparative Physiology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">293</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">R1787</span>
                     <span tagx="lpage">R1797</span>
                     <span class="pub-id'">[10.1152/ajpregu.00059.2007]</span>
                     <span class="pub-id'">[2-s2.0-36048948863]</span>
                  </span>
               </li>
            </ul>
         </div>
      </back>
      <div tagxxx="floats-group">
         <div id="tab1">
            <label>Table 1</label>
            <caption>
               <p>Characteristics of electrocardiographic abnormality.</p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th>Characteristic</th>
                     <th>
                        <i>n</i> (%)
                     </th>
                     <th>With left ventricle damage, 
                        <i>n</i>
                     </th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Persistent atrial fibrillation</td>
                     <td>6 (10.3)</td>
                     <td>3</td>
                  </tr>
                  <tr>
                     <td>Atrioventricular block</td>
                     <td>4 (6.8)</td>
                     <td>3</td>
                  </tr>
                  <tr>
                     <td>ST depression</td>
                     <td>17 (29.3)</td>
                     <td>9</td>
                  </tr>
                  <tr>
                     <td>Negative T wave</td>
                     <td>17 (29.3)</td>
                     <td>8</td>
                  </tr>
               </tbody>
            </table>
         </div>
         <div id="tab2">
            <label>Table 2</label>
            <caption>
               <p>Clinical characteristics of patients with myasthenia gravis.</p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th> </th>
                     <th>With ECG abnormality (
                        <i>n</i> = 33)
                     </th>
                     <th>Without ECG abnormality (
                        <i>n</i> = 25)
                     </th>
                     <th>
                        <i>p</i> value
                     </th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Male, 
                        <i>n</i> (%)
                     </td>
                     <td>15 (48.4)</td>
                     <td>9 (50.6)</td>
                     <td>0.903</td>
                  </tr>
                  <tr>
                     <td>Age, mean ± SD, y</td>
                     <td>60 ± 5.2</td>
                     <td>58 ± 6.1</td>
                     <td>0.67</td>
                  </tr>
                  <tr>
                     <td>Time from diagnosis, mean ± SD, y</td>
                     <td>12 ± 8.0</td>
                     <td>11 ± 7.1</td>
                     <td>0.67</td>
                  </tr>
                  <tr>
                     <td>Thymoma, 
                        <i>n</i> (%)
                     </td>
                     <td>8 (24.2)</td>
                     <td>10 (40)</td>
                     <td>0.08</td>
                  </tr>
                  <tr>
                     <td>Comorbidities, 
                        <i>n</i>
                     </td>
                     <td> </td>
                     <td> </td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Diabetes mellitus</td>
                     <td>1 </td>
                     <td>2</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Systemic lupus </td>
                     <td>1 </td>
                     <td>2</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Rheumatoid arthritis </td>
                     <td>0</td>
                     <td>1</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Sjogren disease</td>
                     <td>0</td>
                     <td>1</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td>Death, 
                        <i>n</i>
                     </td>
                     <td>3</td>
                     <td>3</td>
                     <td>0.512</td>
                  </tr>
                  <tr>
                     <td>Cause of death, 
                        <i>n</i>
                     </td>
                     <td> </td>
                     <td> </td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Malignancy</td>
                     <td>1 </td>
                     <td>2</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Heart failure</td>
                     <td>1 </td>
                     <td> </td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Acute myocardial infarction</td>
                     <td>1</td>
                     <td> </td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Aplastic anemia</td>
                     <td> </td>
                     <td>1</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td>Type of treatment, 
                        <i>n</i> (%)
                     </td>
                     <td> </td>
                     <td> </td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Steroid</td>
                     <td>19 (55.4)</td>
                     <td>10 (40.0)</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Cholinesterase inhibitor</td>
                     <td>14 (34.5)</td>
                     <td>7 (28.0)</td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td>  Immunosuppressant</td>
                     <td>12 (34.2)</td>
                     <td>11 (44.0)</td>
                     <td> </td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <fn>
                  <p>ECG: electrocardiography; LV: left ventricle.</p>
               </fn>
            </table-wrap-foot>
         </div>
         <div id="tab3">
            <label>Table 3</label>
            <caption>
               <p>Echocardiographic parameters of patients with myasthenia gravis.</p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th> </th>
                     <th>With ECG abnormality (
                        <i>n</i> = 33)
                     </th>
                     <th>Without ECG abnormality (
                        <i>n</i> = 25)
                     </th>
                     <th>
                        <i>p</i> value
                     </th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Ejection fraction (%)</td>
                     <td>61.2 ± 15.1</td>
                     <td>66.1 ± 4.8</td>
                     <td>0.16</td>
                  </tr>
                  <tr>
                     <td>LV end-diastolic dimension (mm)</td>
                     <td>44.7 ± 5.8</td>
                     <td>47.6 ± 7.3</td>
                     <td>0.14</td>
                  </tr>
                  <tr>
                     <td>LV end-systolic dimension (mm)</td>
                     <td>31.8 ± 9.5</td>
                     <td>28.4 ± 4.3</td>
                     <td>0.90</td>
                  </tr>
                  <tr>
                     <td>Septal wall thickness (mm)</td>
                     <td>8.9 ± 1.6</td>
                     <td>8.8 ± 1.1</td>
                     <td>0.63</td>
                  </tr>
                  <tr>
                     <td>
                        <i>E</i>/
                        <i>e</i>′
                     </td>
                     <td>11.2 ± 3.2</td>
                     <td>8.7 ± 2.2</td>
                     <td>0.03</td>
                  </tr>
                  <tr>
                     <td>Left atrium diameter (mm)</td>
                     <td>36.5 ± 6.6</td>
                     <td>34.1 ± 5.6</td>
                     <td>0.20</td>
                  </tr>
                  <tr>
                     <td>Wall motion abnormality</td>
                     <td>5; diffuse</td>
                     <td>0</td>
                     <td> </td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <fn>
                  <p>LV: left ventricle.</p>
               </fn>
            </table-wrap-foot>
         </div>
         <div id="tab4">
            <label>Table 4</label>
            <caption>
               <p>Data concerning the LV damage and ECG abnormality.</p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th> </th>
                     <th>With LV damage</th>
                     <th>Without LV damage</th>
                     <th>(
                        <i>n</i>)
                     </th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>With ECG abnormality</td>
                     <td>14 (5 with reduced EF)</td>
                     <td>11 </td>
                     <td>25</td>
                  </tr>
                  <tr>
                     <td>Without ECG abnormality</td>
                     <td>6 (0 with reduced EF)</td>
                     <td>27 </td>
                     <td>33</td>
                  </tr>
                  <tr>
                     <td>(
                        <i>n</i>)
                     </td>
                     <td>20</td>
                     <td>38</td>
                     <td>58</td>
                  </tr>
               </tbody>
            </table>
         </div>
      </div>
   </article>
</html>